Between January 1995 and July 2007, 18 patients with pathologically confirmed EES were treated at Sun Yatsen University Cancer Center , among whom there were 13 males and 5 females, with a male to female ratio of 2.6:1. Age ranged from 8 months to 60 years, with a median age of 17 years. The age distributions are as follows: four patients were aged 臆 10 years, 8 patients were 1020 years, 2 patients were 2030 years, 4 patients were > 30 years, and 12 patients (66.7% ) were 525 years.
Among the 18 patients, 8 (44.4% ) patients had tumors originated from lower extremities, 5 patients (27.8% ) from paravertebral region, 2 (11.1% ) from chest wall, and the remainder originated from upper limb, pelvic and submandibular area each (5.6% ). In this group, 16 patients (88.9% ) had masses, 5 (27.8%) had local pain, 1 (5.6%) had weight loss, 1 (5.6% ) had cough and 1 (5.6% ) had physical activity limitation. The minimal diameter of the tumors was 2 cm and the maximum was 15 cm, with a median of 4.5 cm.
Among 18 patients, 13 patients received CT examination and 5 patients received MR examination. All the imaging examinations showed the soft tissue masses with a less clearcut boundary, and the adjacent structures shifted by pressure or were invaded (Figure 1 ). All patients completed chest Xray or CT examinations, and 1 patient developed lung metastasis; 8 patients completed bone scan, and none had bone metastasis.
窑 Clinical Research窑
All the 18 patients were pathologically confirmed by our hospital or the Medical College of Sun Yatsen University. Under microscopy it was showed that tumor cells were small, round or oval with little cytoplasm, and nuclei were round or oval with various mitosis; cells were arranged sheet or nestlike, and rosettes could be seen in some patients (Figure 1 ). Immunohistochemical examinations were performed in all the patients, in which Vimpositive rate was 87.5% (14/16) and CD99positive rate was 93.3% (14/15) ( Table 1) .
Among 18 patients, 16 received comprehensive treatment, including radiotherapy plus chemotherapy in 3 patients, surgery plus chemotherapy in 4 patients, surgery plus radiotherapy plus chemotherapy in 9 patients; 2 patients received noncomprehensive treatment, including chemotherapy and surgery alone in 1 patient each. A total of 13 patients received continuous radiotherapy by 60 Co 酌 ray or X ray, and the radiation dose ranged from 24 to 70 Gy, with a median dose of 54 Gy. In the patients treated with chemotherapy, 9 patients received alternating chemotherapy of CAV (CTX + ADM + VCR) and IE (IFO + VP16), 4 patients received MAID (ADM + IFO + DTIC) regimen, and the others received combined chemotherapy based on CTX, ADM, DDP, IFO, VP16 or VCR. SPSS11.0 statistical package was used for statistical analysis of all data, and KaplanMeier method was used for survival and univariate analysis.
Item
The 18 patients in this group were followed up until December 2008, 1 patient was lost to followup, and the followup rate was 94.4%. The survival time of 17 patients ranged from 6 to 118 months ( Figure 3 ). Three patients had residual tumor, 2 had recurrence, 2 had pulmonary metastases, and 2 had bone metastases. The 1, 3 and 5year survival rates were 82.4%, 64.2% and 32.1%, respectively.
The factors related to prognosis (including gender, age, tumor size, tumor location, with or without distant metastasis, with or without anemia, LDH levels, treatment modality, efficacy) were analyzed by univariate analysis, and the result showed that (Table 2 ).
EES has a low incidence rate, accounts for 1.1% of malignant soft tissue tumors [4] , and most often occurs in young people ranging in age from 15 to 30 years, rarely more than 40 years, and is more common in men [5] . In this group, 66.7% of the patients were aged 525 years, with a male to female ratio of 2.6:1, which basically agrees with the reports in the literatures (Table 3) .
Authors Kinsella et al. [6] Rud et al. [7] Raney et al. [3] Ahmad et al. [8] Castex et al. EES occurs mainly at paravertebral region, lower limb and chest wall, and a few occur in the pelvic cavity, retroperitoneal region, upper limb and head and neck [3] . In this group, tumors originated from lower extremities in 8 patients (44.4% ), from paravertebral region in 5 patients (27.8%), and from chest wall in 2 patients (11.1% ), which was consistent with the reports in the literature. The main clinical symptoms of this disease is the mass deep in the soft tissue, generally without red, swollen, fever and other inflammatory signs in the surface, and local pain may occur in some patients. When the mass grows to a certain degree, it can limit the activity of local muscle and oppress the surrounding tissue. The mass occurring in the spinal canal or near the nerve can cause sensory and movement disorder of the nerverelated limb.
The imaging of EES is different from that of bone Ewing爷s sarcoma since they originate from different sites. EES has very few direct violation to bone, and its imaging showed soft tissue mass with unclear boundary and changes of hemorrhage, cystic change and necrosis, but without significant calcification [4, 10] . Xray film shows soft tissue mass with muscle tissue density, the peripheral soft tissue swelling, pressured and displaced, or invaded, but without calcification and onion skinlike radiation characteristics which is specific to bone Ewing爷s sarcoma. Unenhanced CT imaging shows mass with hypodensity or uneven density and unclear edges due to the hemorrhagic necrosis, and the surrounding tissues show pressured shift and invaded changes; enhanced scan shows that the mass is heterogeneously enhanced. Unenhanced T1weighted MRI shows mass with low signal or equal signal and tumor hemorrhage with high signal; T2weighted MRI shows mass with slightly higher signal, and enhanced scan shows heterogeneously enhanced mass. The patients in this group all showed soft tissue masses with unclear boundary, and the surrounding tissue showed pressured shift and invaded changes, which was consistent with those reported in the literature.
Since this disease has a high rate of distant metastasis, and the most common sites of metastases are lung and bone, it is suggested that chest Xray or CT and bone scan should be done before treatment to exclude distant metastasis and make a clear stage. With the clinical application of PET/CT, we believe that it is more timely and accurate than traditional imaging methods, and it has significant value in staging before treatment and finding tumor recurrence and metastasis after treatment.
EES has no specific clinical manifestation, so timely pathological biopsy is the principal means to clarify a diagnosis. Under ordinary optical microscope this disease usually presents poorly differentiated small round cells, so it should be differentiated with small round cell tumor occurring in soft tissues, such as metastatic neuroblastoma, alveolar rhabdomyosarcoma, metastatic small cell carcinoma, PNET and malignant lymphoma. Ewing爷s sarcoma and PNET have similar characteristics in morphology, cytogenetics, tumor gene expression in the original agreement, cell culture, immunohistochemical and ultrastructural structure, so they are difficult to be differentiated by light microscopy. In general, under ordinary optical microscope, Ewing爷s sarcoma shows small round cells with tight piece or lobular distribution, and among the interlobules is the fibrous connective tissue with various width intervals; nuclear shape is regular, round or oval, with clear nuclear membrane and various mitoses, and cytoplasm is sparse or shows irregularshaped small vacuoles, with some rosettes structures [11] . Immunohistochemistry shows positive PSA, CD99, Vimentin, various expressions of NSE, SYP, Leu7, and negative S100, NF. Electron microscopy shows sparse organelles, undeveloped Golgi apparatus, and glycogen granules can be seen in cytoplasm. Relatively speaking, the nucleus of PNET tumor cell has more cohesion and deep dyeing chromatin with small nucleolus, and the cytoplasm is sparse or unclear. Furthermore, in some tumors, twophase morphology can be seen, which is compounded by cells with less volume, deepdyed nuclear, scarce cytoplasm, morphologically similar to small lymphocytes, and mediumlarge cells with larger volume, vacuolelike nuclear chromatin, relatively abundant and pale staining cytoplasm, morphologically similar to the epithelial cells. In addition to tablets or lobular distribution, sometimes the tumor cells show beamlike or fascicular arrangement similar to small cell carcinoma or carcinoid tumors and with HW rosettes arrangement. Immunohistochemistry shows the expression of at least two kinds of different neural markers. The electron microscopy confirms that the cells contain neuroendocrine granules.
The clinical diagnosis of EES is difficult. According to our cases and those reported in the literature, we think the main reasons are as follows: (1) the incidence rate is low and doctors have low vigilance; (2) it has no specific characteristics in symptoms, signs and imaging; and (3) it has no typical histological features and it is easy to make pathological misdiagnosis. The exact diagnosis of EES relies mainly on pathology, but it has no typical characteristics of pathological manifestations under ordinary optical microscope. So for some young patients with poorly differentiated or undifferentiated tumor cells, which are difficult to be differentiated with other tumors, immunohistochemical examination should be performed to determine the source tissue and make a clear diagnosis. Furthermore , since 90 % 95 % of Ewing 爷 s sarcoma has a characteristic t (11; 22) (q24; q12) chromosomal translocation, which results in the fusion of FIL1 gene on 11q24 with EWS gene on 22q12, and generate EWS FLI1 fusion gene [1214] , we can specifically detect and diagnose Ewing爷s sarcoma by detecting EWSFLI1 and t(11; 22) with RTPCR and FISH.
EES has the same chromosomal translocation with bone Ewing爷s sarcoma, and at present it is considered that the standard treatment used in the bone Ewing爷s sarcoma can achieve a good therapeutic effect in EES [14, 15] . The main treatment for EES is chemotherapy, surgery and radiotherapybased comprehensive treatment. This study showed that the treatment modality which patients accepted had a significant effect on the prognosis, and the prognosis of comprehensive treatment group was significantly better than that of noncomprehensive treatment group ( = 0.05). Rud [7] . retrospectively analyzed 42 cases of EES , and the results showed that comprehensive treatment could improve the survival rate, and adjuvant radiotherapy could improve the local control rate in margin positive patients; and adjuvant chemotherapy could eliminate micrometastases in all patients. The treatment recommended by 2009 NCCN bone tumor guideline is chemotherapy plus local treatment (surgery and / or radiotherapy) plus chemotherapy. Multidrug combination chemotherapy is recommended, and recommended drugs include cyclophosphamide, ifosfamide, etoposide, doxorubicin and vincristine. In this group, CAV / IE alternating chemotherapy was mostly used. It has been confirmed that CAVD (CTX + ADM + VCR + DACT) / IE alternating chemotherapy can improve the metastasisfree survival rate of bone Ewing爷s sarcoma and primitive neuroectodermal tumor when compared with CAVD alone, but there is no significant statistical difference for the patients with metastasis [16] . In addition, doxorubicin also has an important status in the treatment. Castex [9] compared the treatment programs of EES by the International Pediatric Oncology Society (SIOP) and the French Pediatric Oncology Society (SFOP) (SIOP used malignant stromal tumor treatment program, and SFOP used bone Ewing爷s sarcoma treatment program), and the results showed that the 5year overall survival rates were 59% and 83% , respectively, and treatment program adopted turned out to be the only factor affecting the survival rate. After comparing the two treatment programs, the authors considered that the use of anthracycline drug resulted in improved survival rate of EES. The main local treatments of EES are surgery and radiotherapy. The current view is that surgical resection should be performed if the tumor can be completely resected. Multidrug chemotherapy should be given for 1224 weeks before surgery. A local wide resection is the recommended operation [7, 8, 17] , with the goal of a complete resection of tumor lesions and negative surgical margin, and the extent should include a 23 cm normal tissue surrounding the tumor if possible. If the surgical margin is positive or insufficient, or the tumor locates at a special site or is bulky with wide invasion and hard to be resected, radiotherapy may be practicable. Both the dose and scope of radiotherapy can refer to bone Ewing爷s sarcoma. Since adequate clinical evidence is deficient to confirm the difference of surgery and radiotherapy in tumor control rate, individualized treatment program should be chosen according to patient爷s specific circumstances.
Most authors believe that EES has a better prognosis, with a 5year survival rate above 60% , and prognostic factors are age, tumor location, tumor size, with or without distant metastasis, genetic mutation type and treatment programs [79, 14] . This study shows that the main factors influencing the prognosis are distant metastasis and treatment modality. We think that early diagnosis, clear stage and active individualized comprehensive treatment are the keys to improving the therapeutic efficacy for EES.
